| Saad M, Cassagnol M
Use of the MDRD study equation for drug dosing. [Comment, Letter]
Am J Kidney Dis 2009 Nov; 54(5):984; author reply 985-6.
Full Citation | Publisher Full Text | Find Related Articles |
| Dowling TC, Matzke GR, Murphy JE
Estimated GFR vs creatinine clearance for drug dosing. [Comment, Letter]
Am J Kidney Dis 2009 Nov; 54(5):984-5; author reply 985-6.
Full Citation | Publisher Full Text | Find Related Articles |
| Czock D, Bertsche T, Haefeli WE
Drug dose adjustments in patients with renal impairment. [Comment, Letter]
Am J Kidney Dis 2009 Nov; 54(5):983-4; author reply 985-6.
Full Citation | Publisher Full Text | Find Related Articles |
| Jones GR
Estimated GFR for drug dosing: a bedside formula. [Comment, Letter]
Am J Kidney Dis 2009 Nov; 54(5):982-3; author reply 985-6.
Full Citation | Publisher Full Text | Find Related Articles |
| Spruill WJ, Wade WE, Cobb HH
Continuing the use of the Cockcroft-Gault equation for drug dosing in patients with impaired renal function. [Journal Article]
Clin Pharmacol Ther 2009 Nov; 86(5):468-70.
Full Citation | Publisher Full Text | Find Related Articles |
| Stevens LA, Levey AS
Use of the MDRD study equation to estimate kidney function for drug dosing. [Journal Article]
Clin Pharmacol Ther 2009 Nov; 86(5):465-7.
Full Citation | Publisher Full Text | Find Related Articles |
| Musuamba FT, Rousseau A, Bosmans JL, et al.
Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus. [JOURNAL ARTICLE]
Clin Pharmacokinet 2009 Nov 1; 48(11):745-758.
Abstract | Full Citation |
| Budnitz DS, Lewis LL, Shehab N, et al.
CDC and FDA Response to Risk of Confusion in Dosing Tamiflu Oral Suspension. [JOURNAL ARTICLE]
N Engl J Med 2009 Sep 30.
Full Citation | Find Related Articles |
| Woodward S
On how to improve drug use to minimise risks to patients. [Journal Article]
Nurs Times 2009 Sep 8-14; 105(35):33.
Full Citation | Find Related Articles |
| Lalonde RL, Wagner JA
Drug development perspective on pharmacokinetic studies of new drugs in patients with renal impairment. [Journal Article]
Clin Pharmacol Ther 2009 Nov; 86(5):557-61.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
